agilon health (NYSE:AGL) Hits New 12-Month Low - What's Next?

agilon health, inc. (NYSE:AGL - Get Free Report) shares hit a new 52-week low during trading on Friday . The stock traded as low as $2.98 and last traded at $2.98, with a volume of 3058207 shares traded. The stock had previously closed at $3.30.

Wall Street Analyst Weigh In

Several research analysts recently commented on AGL shares. Evercore ISI reduced their price objective on agilon health from $7.00 to $4.00 and set an "in-line" rating for the company in a research note on Tuesday, October 8th. Benchmark reissued a "buy" rating and issued a $9.00 price target on shares of agilon health in a research note on Thursday, August 8th. Royal Bank of Canada restated an "outperform" rating and set a $8.00 price target on shares of agilon health in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of agilon health from $5.00 to $4.00 and set a "hold" rating for the company in a report on Friday, August 9th. Finally, Bank of America cut agilon health from a "buy" rating to an "underperform" rating and set a $3.00 target price on the stock. in a report on Wednesday, October 2nd. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $8.03.

agilon health Price Performance

The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. The company has a market cap of $1.23 billion, a price-to-earnings ratio of -4.26 and a beta of 0.54. The stock's 50-day simple moving average is $3.87 and its 200 day simple moving average is $5.23.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the business posted ($0.04) EPS. The business's revenue for the quarter was up 38.7% compared to the same quarter last year. On average, equities research analysts anticipate that agilon health, inc. will post -0.32 EPS for the current fiscal year.

Insider Activity

In other news, CEO Steven Sell bought 20,000 shares of the firm's stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 3.20% of the company's stock.

Institutional Investors Weigh In On agilon health

A number of hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in shares of agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company's stock worth $176,582,000 after acquiring an additional 371,537 shares during the period. Capital International Investors raised its position in agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company's stock valued at $123,207,000 after purchasing an additional 9,263,296 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock valued at $8,871,000 after buying an additional 1,316,990 shares during the period. Bank of New York Mellon Corp grew its position in shares of agilon health by 18.7% during the second quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company's stock worth $7,252,000 after buying an additional 174,883 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC increased its stake in shares of agilon health by 65.0% during the second quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company's stock worth $5,262,000 after buying an additional 316,856 shares during the period.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.